Loading data
CMNDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 2.06 m USD | 1.38 m USD | 1.54 m USD | 3.08 m USD |
| Selling, general and administrative expense | — | 4.36 m USD | 4.76 m USD | 3.17 m USD |
| Interest expense | 3.86 k USD | 5.39 k USD | — | — |
| Profit before tax | -3.79 m USD | -4.88 m USD | -8.6 m USD | -6.87 m USD |
| Income tax expense | 70.45 k USD | 377.97 k USD | 17.37 k USD | 29.86 k USD |
| Net income (reported basis) | -3.86 m USD | -5.25 m USD | -8.62 m USD | -6.89 m USD |
| Basic earnings per share | -30.35 USD/share | -67.8 USD/share | -1,703.04 USD/share | -159.11 USD/share |
| Diluted earnings per share | -30.35 USD/share | -67.8 USD/share | -1,703.04 USD/share | -159.11 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.